News Articles Tagged: New Treatments

Retatrutide: The Future of Weight Loss APIs for Pharma

Explore Retatrutide's role as a next-gen Active Pharmaceutical Ingredient (API) for weight loss. NINGBO INNO PHARMCHEM CO.,LTD. offers high-purity Retatrutide for your formulation needs.

Innovations in Ulcerative Colitis Treatment: The Etrasimod Advantage

Discover how Etrasimod, a new oral S1P receptor modulator, is changing the landscape of ulcerative colitis treatment, offering a unique advantage for patients.